Gerd Kochendoerfer has over 20 years of experience in leadership roles in small and medium-sized pharmaceutical/biotech organizations in both early/late stage development and commercial settings. Leadership roles include cross-functional teams developing technology innovation, building development pipelines, and supporting commercial launches, as well as strategic and operational oversight for development operations departments. He was a member of diligence and deal teams responsible for numerous product acquisitions and in and out-licensing deals, and member of steering committees for key strategic alliances. Prior to joining Nflection, Gerd was Senior VP and Head of Operations at PellePharm, a BridgeBio company. Prior, Gerd helped transform Depomed from a small drug delivery company to a major specialty pharma company in the pain and neurology space as Senior Vice President. Earlier in his career, Gerd held research and drug development management positions at FibroGen, leading the Roxadustat program, and Gryphon Therapeutics, building a pipeline of engineered and/or polymer-modified protein therapeutics. Gerd holds a Ph.D. in Chemistry from the University of California at Berkeley. He has published more than 25 papers in peer-reviewed literature and holds multiple patents.